Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways

Bora Inceoglu, Steven L. Jinks, Arzu Ulu, Christine M. Hegedus, Katrin Georgi, Kara R. Schmelzer, Karen Wagner, Paul D. Jones, Christophe Morisseau, Bruce D. Hammock

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

During inflammation, a large amount of arachidonic acid (AA) is released into the cellular milieu and cyclooxygenase enzymes convert this AA to prostaglandins that in turn sensitize pain pathways. However, AA is also converted to natural epoxyeicosatrienoic acids (EETs) by cytochrome P450 enzymes. EET levels are typically regulated by soluble epoxide hydrolase (sEH), the major enzyme degrading EETs. Here we demonstrate that EETs or inhibition of sEH lead to antihyperalgesia by at least 2 spinal mechanisms, first by repressing the induction of the COX2 gene and second by rapidly up-regulating an acute neurosteroid-producing gene, StARD1, which requires the synchronized presence of elevated cAMP and EET levels. The analgesic activities of neurosteroids are well known; however, here we describe a clear course toward augmenting the levels of these molecules. Redirecting the flow of pronociceptive intracellular cAMP toward up-regulation of StARD1 mRNA by concomitantly elevating EETs is a novel path to accomplish pain relief in both inflammatory and neuropathic pain states.

Original languageEnglish (US)
Pages (from-to)18901-18906
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume105
Issue number48
DOIs
StatePublished - Dec 2 2008

Fingerprint

Epoxide Hydrolases
Arachidonic Acid
Analgesics
Cytochrome P-450 Enzyme System
Acids
Neurotransmitter Agents
Pain
Neuralgia
Enzymes
Prostaglandin-Endoperoxide Synthases
Genes
Prostaglandins
Up-Regulation
Inflammation
Messenger RNA

Keywords

  • cAMP
  • Inflammatory pain
  • Steroidogenesis

ASJC Scopus subject areas

  • General

Cite this

Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways. / Inceoglu, Bora; Jinks, Steven L.; Ulu, Arzu; Hegedus, Christine M.; Georgi, Katrin; Schmelzer, Kara R.; Wagner, Karen; Jones, Paul D.; Morisseau, Christophe; Hammock, Bruce D.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 48, 02.12.2008, p. 18901-18906.

Research output: Contribution to journalArticle

Inceoglu, B, Jinks, SL, Ulu, A, Hegedus, CM, Georgi, K, Schmelzer, KR, Wagner, K, Jones, PD, Morisseau, C & Hammock, BD 2008, 'Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways', Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 48, pp. 18901-18906. https://doi.org/10.1073/pnas.0809765105
Inceoglu, Bora ; Jinks, Steven L. ; Ulu, Arzu ; Hegedus, Christine M. ; Georgi, Katrin ; Schmelzer, Kara R. ; Wagner, Karen ; Jones, Paul D. ; Morisseau, Christophe ; Hammock, Bruce D. / Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways. In: Proceedings of the National Academy of Sciences of the United States of America. 2008 ; Vol. 105, No. 48. pp. 18901-18906.
@article{e26ca6327d25489c82b6384d6555644e,
title = "Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways",
abstract = "During inflammation, a large amount of arachidonic acid (AA) is released into the cellular milieu and cyclooxygenase enzymes convert this AA to prostaglandins that in turn sensitize pain pathways. However, AA is also converted to natural epoxyeicosatrienoic acids (EETs) by cytochrome P450 enzymes. EET levels are typically regulated by soluble epoxide hydrolase (sEH), the major enzyme degrading EETs. Here we demonstrate that EETs or inhibition of sEH lead to antihyperalgesia by at least 2 spinal mechanisms, first by repressing the induction of the COX2 gene and second by rapidly up-regulating an acute neurosteroid-producing gene, StARD1, which requires the synchronized presence of elevated cAMP and EET levels. The analgesic activities of neurosteroids are well known; however, here we describe a clear course toward augmenting the levels of these molecules. Redirecting the flow of pronociceptive intracellular cAMP toward up-regulation of StARD1 mRNA by concomitantly elevating EETs is a novel path to accomplish pain relief in both inflammatory and neuropathic pain states.",
keywords = "cAMP, Inflammatory pain, Steroidogenesis",
author = "Bora Inceoglu and Jinks, {Steven L.} and Arzu Ulu and Hegedus, {Christine M.} and Katrin Georgi and Schmelzer, {Kara R.} and Karen Wagner and Jones, {Paul D.} and Christophe Morisseau and Hammock, {Bruce D.}",
year = "2008",
month = "12",
day = "2",
doi = "10.1073/pnas.0809765105",
language = "English (US)",
volume = "105",
pages = "18901--18906",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "48",

}

TY - JOUR

T1 - Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways

AU - Inceoglu, Bora

AU - Jinks, Steven L.

AU - Ulu, Arzu

AU - Hegedus, Christine M.

AU - Georgi, Katrin

AU - Schmelzer, Kara R.

AU - Wagner, Karen

AU - Jones, Paul D.

AU - Morisseau, Christophe

AU - Hammock, Bruce D.

PY - 2008/12/2

Y1 - 2008/12/2

N2 - During inflammation, a large amount of arachidonic acid (AA) is released into the cellular milieu and cyclooxygenase enzymes convert this AA to prostaglandins that in turn sensitize pain pathways. However, AA is also converted to natural epoxyeicosatrienoic acids (EETs) by cytochrome P450 enzymes. EET levels are typically regulated by soluble epoxide hydrolase (sEH), the major enzyme degrading EETs. Here we demonstrate that EETs or inhibition of sEH lead to antihyperalgesia by at least 2 spinal mechanisms, first by repressing the induction of the COX2 gene and second by rapidly up-regulating an acute neurosteroid-producing gene, StARD1, which requires the synchronized presence of elevated cAMP and EET levels. The analgesic activities of neurosteroids are well known; however, here we describe a clear course toward augmenting the levels of these molecules. Redirecting the flow of pronociceptive intracellular cAMP toward up-regulation of StARD1 mRNA by concomitantly elevating EETs is a novel path to accomplish pain relief in both inflammatory and neuropathic pain states.

AB - During inflammation, a large amount of arachidonic acid (AA) is released into the cellular milieu and cyclooxygenase enzymes convert this AA to prostaglandins that in turn sensitize pain pathways. However, AA is also converted to natural epoxyeicosatrienoic acids (EETs) by cytochrome P450 enzymes. EET levels are typically regulated by soluble epoxide hydrolase (sEH), the major enzyme degrading EETs. Here we demonstrate that EETs or inhibition of sEH lead to antihyperalgesia by at least 2 spinal mechanisms, first by repressing the induction of the COX2 gene and second by rapidly up-regulating an acute neurosteroid-producing gene, StARD1, which requires the synchronized presence of elevated cAMP and EET levels. The analgesic activities of neurosteroids are well known; however, here we describe a clear course toward augmenting the levels of these molecules. Redirecting the flow of pronociceptive intracellular cAMP toward up-regulation of StARD1 mRNA by concomitantly elevating EETs is a novel path to accomplish pain relief in both inflammatory and neuropathic pain states.

KW - cAMP

KW - Inflammatory pain

KW - Steroidogenesis

UR - http://www.scopus.com/inward/record.url?scp=57749091900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57749091900&partnerID=8YFLogxK

U2 - 10.1073/pnas.0809765105

DO - 10.1073/pnas.0809765105

M3 - Article

C2 - 19028872

AN - SCOPUS:57749091900

VL - 105

SP - 18901

EP - 18906

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 48

ER -